FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2085170704> ?p ?o ?g. }

• W2085170704 endingPage "183" @default.
• W2085170704 startingPage "178" @default.
• W2085170704 abstract "Essential thrombocythemia must now be regarded as a heterogeneous disease. Recent availability of clonality studies have repeatedly shown that a significant number of female patients diagnosed as E.T. according the most stringent criteria had a definitely polyclonal myelopoiesis. Although the incidence of patients newly diagnosed every year is low, there is in fact a conspicuous population of E.T., followed as outpatients in every department of hematology or internal medicine, including a large number of young females. These eventualities should be integrated in further discussions of the benefit/risk ratio of cytoreduction with the presently available drugs. The combination of several evidence-based data is the basis of a widely accepted stratification of high-risk patients defined by any of the following features. Age > 60 to 65. History of thrombosis or embolic or major ischemic events. Platelet counts in excess of 1000 or 1500 x 10(9)/L. In the question of chemotherapy in E.T., growing concern comes from the potential leukemogenic risk associated with the presently available drugs and extends beyond Melphalan, Busulfan and other alkylating agents and includes non-alkylating agents like Hydroxyurea. At the same time, much attention has been paid to the introduction of very precise initial diagnostic criteria directed to elimination of other myeloproliferative or myelodysplastic disorders with an increased risk of transformation. Present treatment of E.T. is a compromise between prevention of E.T. related thrombotic and bleeding complications on one hand and long term side effects and toxicity of the presently available drugs on the other hand. The recent availability of non mutagenic drugs like Interferon and most of all Anagrelide; the recognition of the role of antiaggregating agents in the treatment of platelet related microvascular ischemic events gives the opportunity for further comparative prospective trials. The use of aspirin in the management of pregnant E.T. patients is now widely accepted but there is still controversies concerning the use of Interferon in this situation." @default.
• W2085170704 created "2016-06-24" @default.
• W2085170704 creator A5000549535 @default.
• W2085170704 creator A5066639146 @default.
• W2085170704 date "2001-01-01" @default.
• W2085170704 modified "2023-10-07" @default.
• W2085170704 title "Management of patients with essential thrombocythemia: current concepts and perspectives" @default.
• W2085170704 cites W144517407 @default.
• W2085170704 cites W1986329429 @default.
• W2085170704 cites W1993371517 @default.
• W2085170704 cites W1997944331 @default.
• W2085170704 cites W1998325169 @default.
• W2085170704 cites W2004029265 @default.
• W2085170704 cites W2016417342 @default.
• W2085170704 cites W2026076166 @default.
• W2085170704 cites W2029353341 @default.
• W2085170704 cites W2033732447 @default.
• W2085170704 cites W2036143671 @default.
• W2085170704 cites W2050060924 @default.
• W2085170704 cites W2056740371 @default.
• W2085170704 cites W2070714143 @default.
• W2085170704 cites W2076689289 @default.
• W2085170704 cites W2078517764 @default.
• W2085170704 cites W2081737706 @default.
• W2085170704 cites W2082997796 @default.
• W2085170704 cites W2092298450 @default.
• W2085170704 cites W2117054170 @default.
• W2085170704 cites W2119315092 @default.
• W2085170704 cites W2122630697 @default.
• W2085170704 cites W2166047295 @default.
• W2085170704 cites W2229971338 @default.
• W2085170704 cites W2240871144 @default.
• W2085170704 cites W2320032845 @default.
• W2085170704 cites W2331216347 @default.
• W2085170704 cites W2492141817 @default.
• W2085170704 cites W26497377 @default.
• W2085170704 cites W46453237 @default.
• W2085170704 doi "https://doi.org/10.1016/s0369-8114(00)00026-2" @default.
• W2085170704 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11317966" @default.
• W2085170704 hasPublicationYear "2001" @default.
• W2085170704 type Work @default.
• W2085170704 sameAs 2085170704 @default.
• W2085170704 citedByCount "10" @default.
• W2085170704 countsByYear W20851707042015 @default.
• W2085170704 countsByYear W20851707042020 @default.
• W2085170704 crossrefType "journal-article" @default.
• W2085170704 hasAuthorship W2085170704A5000549535 @default.
• W2085170704 hasAuthorship W2085170704A5066639146 @default.
• W2085170704 hasConcept C120665830 @default.
• W2085170704 hasConcept C121332964 @default.
• W2085170704 hasConcept C126322002 @default.
• W2085170704 hasConcept C141071460 @default.
• W2085170704 hasConcept C177713679 @default.
• W2085170704 hasConcept C2776694085 @default.
• W2085170704 hasConcept C2776755627 @default.
• W2085170704 hasConcept C2778684742 @default.
• W2085170704 hasConcept C2778837598 @default.
• W2085170704 hasConcept C2779134260 @default.
• W2085170704 hasConcept C2779316324 @default.
• W2085170704 hasConcept C2780007613 @default.
• W2085170704 hasConcept C2780076729 @default.
• W2085170704 hasConcept C2780611847 @default.
• W2085170704 hasConcept C2780829020 @default.
• W2085170704 hasConcept C2781057849 @default.
• W2085170704 hasConcept C2908647359 @default.
• W2085170704 hasConcept C61511704 @default.
• W2085170704 hasConcept C71924100 @default.
• W2085170704 hasConcept C99454951 @default.
• W2085170704 hasConceptScore W2085170704C120665830 @default.
• W2085170704 hasConceptScore W2085170704C121332964 @default.
• W2085170704 hasConceptScore W2085170704C126322002 @default.
• W2085170704 hasConceptScore W2085170704C141071460 @default.
• W2085170704 hasConceptScore W2085170704C177713679 @default.
• W2085170704 hasConceptScore W2085170704C2776694085 @default.
• W2085170704 hasConceptScore W2085170704C2776755627 @default.
• W2085170704 hasConceptScore W2085170704C2778684742 @default.
• W2085170704 hasConceptScore W2085170704C2778837598 @default.
• W2085170704 hasConceptScore W2085170704C2779134260 @default.
• W2085170704 hasConceptScore W2085170704C2779316324 @default.
• W2085170704 hasConceptScore W2085170704C2780007613 @default.
• W2085170704 hasConceptScore W2085170704C2780076729 @default.
• W2085170704 hasConceptScore W2085170704C2780611847 @default.
• W2085170704 hasConceptScore W2085170704C2780829020 @default.
• W2085170704 hasConceptScore W2085170704C2781057849 @default.
• W2085170704 hasConceptScore W2085170704C2908647359 @default.
• W2085170704 hasConceptScore W2085170704C61511704 @default.
• W2085170704 hasConceptScore W2085170704C71924100 @default.
• W2085170704 hasConceptScore W2085170704C99454951 @default.
• W2085170704 hasIssue "2" @default.
• W2085170704 hasLocation W20851707041 @default.
• W2085170704 hasLocation W20851707042 @default.
• W2085170704 hasOpenAccess W2085170704 @default.
• W2085170704 hasPrimaryLocation W20851707041 @default.
• W2085170704 hasRelatedWork W2011253478 @default.
• W2085170704 hasRelatedWork W2062845857 @default.
• W2085170704 hasRelatedWork W2085170704 @default.
• W2085170704 hasRelatedWork W2088772354 @default.
• W2085170704 hasRelatedWork W2318732531 @default.

• next